vimarsana.com

Page 6 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் ஜென்னர் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Denmark becomes 1st European nation to completely shun AstraZeneca COVID vaccine

Wrexham s MP receives first dose of coronavirus vaccine and urges people to have theirs when contacted

AstraZeneca vaccine co-inventors float on US market is a blow to the UK

AstraZeneca vaccine co-inventors float on US market is a blow to the UK - but it s not all bad news Thursday 8th April 2021 15:15 BST Instead, in what will be seen as a blow to the government s ambitions to make the UK stock market a hub for fast-growing technology and life sciences companies, Vaccitech is to float in the United States. The company was valued at around $425m (£308m) at its most recent funding round, only last month, in which it raised $168m (£122m) from investors including the fund management giant M&G. However, the Wall Street Journal reported last month that the company would be seeking a valuation of $700m (£508m) on flotation, while there has even been speculation that it could be worth as much as $1bn (£730m) by the end of the year.

British scientists behind Vaccitech firm that made Oxford AstraZeneca jab could both get £26m payday

Two of the scientists behind Britain s AstraZeneca jab could both make £26million today as the tech firm that developed it hits the US stock market. Oxford professors Sarah Gilbert and Adrian Hill both own 5.2 per cent of Vaccitech, which will later float on America s Nasdaq exchange. The pair are alongside other scientists and investors who put money and expertise into the company after it was founded in 2016. Companies House papers audited by MailOnline show Profs Gilbert and Hill each hold 2,500 ordinary shares in the firm, out of a total 47,827. Experts have suggested it is targeting a value of some £509 million, meaning if this is realised, the two scientists stakes will be each worth £26.4million.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.